176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-15.45%
Negative net income growth while TSM stands at 3.47%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-4.17%
Negative yoy D&A while TSM is 0.30%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-35.71%
Negative yoy deferred tax while TSM stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
13.46%
SBC growth of 13.46% while TSM is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
206.08%
Well above TSM's 202.46% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
240.91%
AR growth well above TSM's 95.87%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-58.82%
Both reduce yoy inventory, with TSM at -23.80%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-190.00%
Both negative yoy AP, with TSM at -36.98%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
184.05%
Growth well above TSM's 260.40%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-6.67%
Negative yoy while TSM is 90.69%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
100.39%
Operating cash flow growth above 1.5x TSM's 46.52%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
11.76%
Some CapEx rise while TSM is negative at -8.40%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.97%
Both yoy lines are negative, with TSM at -19.32%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-200.00%
Both yoy lines negative, with TSM at -63.74%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-7.04%
Both yoy lines negative, with TSM at -29.58%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-200.00%
We cut debt repayment yoy while TSM is 98.71%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.